Navigation Links
Roche Engages in Four Additional AIDS Technology Transfers to Strengthen Local Manufacturing in World's Poorest Countries
Date:1/9/2008

- Free-of-charge expertise for factories in Bangladesh, Kenya, Tanzania and

Zimbabwe -

NUTLEY, N.J., Jan. 9 /PRNewswire/ -- Roche today announced that it has entered into four new technology transfers with local manufacturing companies in African and Asian nations where improvements in access to anti-retroviral therapy are needed. These companies are Regal Pharmaceuticals in Kenya, CAPS Holdings in Zimbabwe, Shelys Pharmaceuticals in Tanzania and Beximco Pharmaceuticals Ltd in Bangladesh. As part of Roche's Technology Transfer Initiative, these companies will be provided free of charge with the technical expertise to manufacture generic HIV medicine, based upon the processes to produce saquinavir, Roche's second line(1) HIV medicine.

Since the launch two years ago, Roche has signed Technology Transfer agreements with a total of nine companies across sub-Saharan Africa and in Least Developed Countries in other parts of the world. Roche also has received similar requests from a total of 35 manufacturers in 15 eligible countries, including Kenya, Ghana, Zimbabwe and Nigeria. Roche will continue to work with these individual applicants to assess production capabilities.

William M. Burns, CEO Division Roche Pharma, said, "these new agreements highlight the ongoing contribution that our Roche Technology Transfer Initiative is making to help strengthen and expand local manufacturing capabilities for HIV medicines in resource-limited countries. With more local manufacturers now looking to scale-up production of essential medicines, the continued uptake of this initiative highlights Roche as an innovative leader in supporting sustainable solutions to improve HIV healthcare where it is needed most."

In addition to these four new agreements, Roche has expanded the Technology Transfer Initiative with training seminars for local manufacturers across sub-Saharan Africa and the world's Least Developed Countries. The
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Neurochem to present at JPMorgan Healthcare Conference
2. Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
3. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
4. David Luci Joins MacroChem as General Counsel and Vice President Corporate Development
5. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
6. Rochester Medical Reports Record Fourth Quarter Sales and Record Year
7. Roche Confirms Commencement of Due Diligence with Ventana
8. Neurochem reports results for third quarter of fiscal 2007
9. Roche Offers Innovative Website Designed to Empower Cancer Patients
10. Roche Extends Tender Offer for Ventana
11. Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 instruments

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)...isk continues for 12 weeks and includes minimally ...RSDAY, Dec. 3 (HealthDay News) -- Potentially fata...k than has previously been thought, a British stud...nly is the risk higher, but that it lasts much lon..., a clinical epidemiologist at the University of O...
(Date:12/3/2009)... Economic downturn causes ...ams. Mountainside in Connecticut cites a sharp inc...ress caused by economic crisis which has led to an...and marital problems. , (... Addiction Treatment Center sees a huge spike in d...
(Date:12/3/2009)..., , LONDON, Dec. 3 Chil...inical research organization (CRO) providing clini...he Americas and Asia, today announces the appointm...ent, Global Quality & Medical Affairs. Dr. Moo...office. ,, Dr. Moore is a physician with 15 yea...
(Date:12/3/2009)..., , SARASOTA, Fla., Dec. 3 /PRNewswire/ ... documentary, get ready for a stunning look at the...aker Jenna Norwood will screen her feature documen...versity on Tuesday, December 8th, 5 p.m. at Sever ... "Supercharged Living" College Tour. The film will...
(Date:12/3/2009)...ithout need to fly far for food, wing shapes chang..., Dec. 3 (HealthDay News) -- Many people think evo... but it can happen much faster and new research sh...n winter appears to be having an effect on a popul...r findings in the Dec. 3 online edition of Curren...
Breaking Medicine News(10 mins):Health News:Blood Clot Threat After Surgery Worse Than Thought 2Health News:Blood Clot Threat After Surgery Worse Than Thought 3Health News:Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 2Health News:Chiltern Names Dr. Sharon Moore as Executive VP, Global Quality & Medical Affairs 2Health News:Jenna Norwood to Present Award-Winning Documentary & Lecture at Harvard University 2Health News:Feeding Birds in Winter Could Speed Evolution of Species 2
...ger Institute will commemorate World,Autism Awaren...he one-year anniversary of the Interactive Autism ... , Launched in April 2007 by the Kennedy Krieger ... an online network that links parents to researche...
... health campaign created by an alliance of nationa...ched today in Washington, DC. The program,called E...difficult process,of quitting, and guide them to v...lth organizations aligned to,get a smoking cessati...
...d Focus on Delivering on 200... 31 LodgeNet,Interactive Corporation (Nasdaq: LN...ty solutions to hospitality and healthcare busines...discuss its,progress in creating and driving its s...
...open,the door on Congressional proceedings and oth...day is doing for medical professionals via its liv...ces., MedPage Today is the innovative source of m...April 1, 2008, MedPage Today will be broadcasting,...
...ding,innovator of physiological monitoring solutio...of interoperability with other medical equipment.,... innovative technologies,that facilitate informati...t healthcare and technology companies in,the world...
...ity-based registry of patients treated with drug-e...how long patients with complex coronary artery dis...ke clopidogrel, a drug that prevents unwanted bloo... of which represents off-label use of sirolimus-el...
Other Medicine News:Health News:First national autism registry shows notable impact on autism research in opening year 2Health News:New National Public Health Program Shows Smokers How to Become an EX 2Health News:New National Public Health Program Shows Smokers How to Become an EX 3Health News:New National Public Health Program Shows Smokers How to Become an EX 4Health News:New National Public Health Program Shows Smokers How to Become an EX 5Health News:LodgeNet Interactive to Present at The B. Riley Investor Conference 2Health News:LodgeNet Interactive to Present at The B. Riley Investor Conference 3Health News:LodgeNet Interactive to Present at The B. Riley Investor Conference 4Health News:LodgeNet Interactive to Present at The B. Riley Investor Conference 5Health News:MedPage Today(R) Provides First-Time Live Video Coverage of Medical Meeting Press Conferences 2Health News:Nonin Medical, Inc. Is Recognized for Its Role in Promoting Interoperability 2Health News:Matrix registry probes adherence to clopidogrel at 1 year 2Health News:Matrix registry probes adherence to clopidogrel at 1 year 3
(Date:12/3/2009)...RNewswire-FirstCall/ -- Jazz Pharmaceuticals, Inc....Falberg has been appointed Senior Vice President a... Jazz Pharmaceuticals more than 20 years of financ...maceutical,s CFO, Ms. Falberg will be responsible ...inancial planning, investor relations, and treasur...
(Date:12/3/2009)...ewswire-FirstCall/ -- ULURU Inc. (NYSE ULU) a...., one of the major pharmaceutical distributors in...one of its suppliers and has placed its first sign...Surgical delivers a comprehensive offering of medi...h care technology-related services to the alternat...
(Date:12/3/2009)...Newswire-FirstCall/ -- Stryker Corporation (NYSE: ...s has authorized the Company to repurchase up to $...ng and amount of any purchases will be determined ...ion of market conditions, stock price and other fa...ions. Purchases may be made from time to time in ...
Breaking Medicine Technology:ULURU Inc. Obtains Status of Approved Supplier With McKesson. 2Stryker Announces $750 Million Share Repurchase Program and Declares a $0.15 Per Share Quarterly Dividend 2Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 1Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 2Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 3Physician Hospitals 28PHA 29 Responds to TIME Magazine Article 3A Filled With Incorrect Assumption and Innuendo 51747 4FertilityAuthority Introduces E Newsletter The Daily Shot 51744 1FertilityAuthority Introduces E Newsletter The Daily Shot 51744 2MultiNational Underwriters Is Now HCC Medical Insurance Services 51740 1MultiNational Underwriters Is Now HCC Medical Insurance Services 51740 2
...1012 coadministered with statins for only five wee...els achieved with,statins alone, with similarly fa...RLEANS and CARLSBAD, Calif., March 26, 2007,/PRNew...ounced new,results from its Phase 2 clinical trial...ted today at the of Cardiology,Annual Scientific S...
...sentation of Comparative Data from ECLIPSE, Larges...gents, NEW ORLEANS, March 27, 2007 /PRNewswire-Fir...al drug Cleviprex(TM) (clevidipine),compared to cu...olling perioperative hypertension -- a potentially...during and/or after,surgery -- were presented for ...
Other Medicine Technology:Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 2Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 3Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 4Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 5Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 6Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 7Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 8Study Presented at ACC Shows Treatment With ISIS 301012 Added to,Statins for Only 5 Weeks Results in 75% of Patients Achieving LDL-C,Levels Less Than 100 mg/dL and 50% of Patients Achieving LDL-C,Levels of Less Than 70 mg/dL 9Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 2Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 3Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 4Pivotal Phase III Findings With Investigational Drug Cleviprex,(Clevidipine) Demonstrate Perioperative Blood Pressure Control In,Cardiac Surgery 5
...a powerful automated system capable of handling an...from 6 user-programmable test protocols to begin a...ny tests not included in the comprehensive list of...oppler, PVR and PPG instrument modes. Provides hig...
CD Horizon M10
Silhouette
...Fixation System combines the flexibility of polyax...rs into a single system. The result is a construc...ng to the vertebral anatomy, thus reducing potenti...ial screws and lateral connectors reduces the pote...
Medicine Products: